Silexion Therapeutics Ltd. (SLXN) NASDAQ
1.07
+0.07(+7.00%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.07
+0.07(+7.00%)
Currency In USD
| Market Cap | 2.55M |
| Enterprise Value | -2.97M |
| P/E Ratio | -0.28 |
| PEG Ratio | 0.02 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.29 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.41 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.65 |
| Return On Equity | -3.88 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -14,000 |
| EBITDA | -11.62M |
| Net Income | -11.91M |
| Diluted EPS | -8.96 |
| Total Cash | 5.99M |
| Total Cash/Share | 1.92 |
| Total Debt | 468,000 |
| Total Debt/Equity | 0.18 |
| Current Ratio | 2.41 |
| Book Value Per Share | 0.83 |
| 52-Week Change | -90.12 |
| 52-Week High | 22.36 |
| 52-Week Low | 0.97 |
| Moving Average 50 Days | 1.45 |
| Moving Average 200 Days | 4.16 |
| Average Volume | 46,390 |
| Shares Outstanding | 560,964 |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
| Last Split Date | July 29, 2025 |